10K-2016: Mikah has accordingly ceased operating and is in the process of winding down and liquidating its assets.
10K-2017:
In May 2017, through Elite Labs, we acquired from Mikah Pharma an FDA approved ANDA for Trimipramine for aggregate consideration of $1,200,000.
It seems like a lot of money for an old ANDA, but the salesman said it was barely used and had been kept in a garage and only driven to church on Sundays by a little old lady from Poughkeepsie.
What's Nasrat's incentive for getting MIKAHs half of Adderall sales to Elite. Having half of Adderall sales (MIKAH) is a comfortable income without ever getting rid of Elite.
Nasrat will have to decided which way makes him more money. Merger is almost his only option to make everyone happy.